CaliberCos Inc.
CWD Nasdaq Real Estate Financials FY2022βFY2025
What CaliberCos Inc. does
No business description yet.
- Legal name
- CaliberCos Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 26, 2026
- Accession Β· CIK
- 0001627282-26-000015
0001627282
Revenue and margins
CaliberCos Inc. had $20.1M of revenue in fiscal 2025, down 60.7% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
CaliberCos Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 157.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably CaliberCos Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Cash and short-term investments | $7.7M | $3.8M | $2.3M | $2.9M |
| Total assets | $279M | $299M | $106M | $135M |
| Total liabilities | $202M | $233M | $94.3M | $109M |
| Shareholders' equity | β$3.2M | $2.6M | β$12.6M | $1.3M |
| Net debt (β = net cash) | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Net income is positive | β | β | β | β |
| Cash from operations is positive | β | β | β | β |
| Return on assets rose | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β |
| Debt fell relative to assets | β | β | β | β |
| Current ratio rose | β | β | β | β |
| Share count didn't rise | β | β | β | β |
| Gross margin rose | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β |
| F-score | β / 3 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | 3.4% | 2.1% | β10.0% | β8.1% |
| Altman Z'' | β | β | β | β |
4 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $84.0M | $90.9M | $51.1M | $20.1M |
| Interest expense | $1.1M | $4.7M | $5.4M | $6.7M |
| Pretax income | $14.0M | β$27.6M | β$21.5M | β$23.0M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | $2.0M | β$12.7M | β$19.8M | β$21.8M |
| Diluted EPS | $0.11 | β$0.63 | β$17.90 | β$7.70 |
| Diluted shares | 0.02B | 0.02B | 0.00B | 0.00B |
| Cash flow | ||||
| Cash from operations | β$7.4M | β$18.7M | $0.6M | β$12.1M |
| Balance sheet | ||||
| Cash and short-term investments | $7.7M | $3.8M | $2.3M | $2.9M |
| Total assets | $279M | $299M | $106M | $135M |
| Total liabilities | $202M | $233M | $94.3M | $109M |
| Preferred stock | $0.0M | β | β | β |
| Shareholders' equity | β$3.2M | $2.6M | β$12.6M | $1.3M |
| Margins | ||||
| Net margin | 2.4% | β14.0% | β38.7% | β108.5% |
| Returns | ||||
| Return on assets | 0.7% | β4.4% | β9.8% | β18.1% |
| Return on tangible equity | β | β484.3% | β | β1,635.3% |
| Growth | ||||
| Revenue growth | β | 8.3% | β43.8% | β60.7% |
| Net income growth | β | β728.9% | β | β |
| EPS growth | β | β672.7% | β | β |
| Share count change | β | 1.3% | β94.5% | 157.3% |
| Quality scores | ||||
| Accruals ratio | 3.4% | 2.1% | β10.0% | β8.1% |
Source: SEC EDGAR XBRL filings (CIK 0001627282). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.